1. Tumor‐targeted fluorescence labeling systems for cancer diagnosis and treatment
   Hiroshi Tazawa et al, 2022, Cancer Science CrossRef
2. Unlocking the Promise of Oncolytic Virotherapy in Glioma: Combination With Chemotherapy to Enhance Efficacy
   Drew A Spencer et al, 2015, Therapeutic Delivery CrossRef
3. An oncolytic adenovirus 11p vector expressing adenovirus death protein in the E1 region showed significant apoptosis and tumour-killing ability in metastatic prostate cells
   Haidong Wu et al, 2019, Oncotarget CrossRef
4. Tamoxifen improves cytopathic effect of oncolytic adenovirus in primary glioblastoma cells mediated through autophagy
   Ilya V. Ulasov et al, 2015, Oncotarget CrossRef
5. Application of conditionally replicating adenoviruses in tumor early diagnosis technology, gene-radiation therapy and chemotherapy
   Shun Li et al, 2016, Applied Microbiology and Biotechnology CrossRef
6. Gene Therapy Leaves a Vicious Cycle
   Reena Goswami et al, 2019, Frontiers in Oncology CrossRef
7. MT1-MMP silencing by an shRNA-armed glioma-targeted conditionally replicative adenovirus (CRAd) improves its anti-glioma efficacy in vitro and in vivo
   Ilya Ulasov et al, 2015, Cancer Letters CrossRef
8. Challenges in development and authorisation of gene therapy products
   A. A. Soldatov et al, 2022, Biological Products. Prevention, Diagnosis, Treatment CrossRef
9. Emerging delivery strategy for oncolytic virotherapy
   Jiao Zhu et al, 2024, Molecular Therapy: Oncology CrossRef